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case of parathyroid carcinoma in a patient with tertiary hyperparathyroidism. Despite a suc-
cessful kidney transplantation, the intact parathyroid hormone (iPTH) level of the patient
was elevated consistently and could not be controlled by medical therapy. Due to the devel-
opment of tertiary hyperparathyroidism with bone pain and osteoporosis, subtotal parathy-
roidectomy was performed 4 months after the kidney transplantation. Histological
evaluation revealed that one of four parathyroid lesions was a parathyroid carcinoma, while
the others were diffuse hyperplasia. Postoperative laboratory studies indicated a decreased
level of iPTH. A positron emission tomographyecomputed tomography performed 6 months af-
ter the operation revealed no evidence of local recurrence or distant metastasis.
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Parathyroid carcinoma is a rare disease of unknown etiol-
ogy.1 Here, we report a case of parathyroid carcinoma in a
patient with tertiary hyperparathyroidism.by Elsevier Taiwan LLC. All rights reserved.
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A 57-year-old man had received long-term hemodialysis (for
11 years) to manage his chronic renal failure caused by
polycystic kidney disease. In 2011, he underwent a kidney
transplant; since then he has never experienced any com-
plications or rejection reactions.
Blood tests performed prior to the kidney trans-
plantation indicated that serum total calcium (Ca) and
ionized Ca levels were 7.2 mg/dL (normal, 8.2e10.4 mg/dL)
and 4.3 mg/dL (normal, 4.5e5.3 mg/dL), respectively.
Serum phosphorus, alkaline phosphatase (ALP), and intact
parathyroid hormone (iPTH) levels were found to be
6.1 mg/dL (normal, 1.9e4.4 mg/dL), 810 IU/L (normal,
104e338 IU/L), and above 1900 pg/mL (normal, 14e72 pg/
mL), respectively. Postoperative laboratory tests per-
formed 3 months following a kidney transplant surgery
showed an elevated level of serum Ca and ALP, which were
increased to 10.6 mg/dL and 1297 IU/L, respectively. Blood
tests also confirmed a slightly decreased level of iPTH,
which was measured to be 1278.4 pg/mL (Fig. 1). The pa-
tient took the medication cinacalcet to manage his mark-
edly elevated serum Ca and iPTH levels, but the treatmentFigure 1 Serum iPTH, ALP, Ca, iCa, albumin, P, and Cr levels
ALP Z alkaline phosphatase; Ca Z calcium; Cr Z creatinine; i
P Z phosphorus.was ineffective. He complained consistently of knee and
ankle pain.
To treat symptomatic tertiary hyperparathyroidism with
osteoporosis, the patient was referred to endocrine sur-
geon. The mean T-score of the lumbar spine (L1eL4),
measured by dual-energy X-ray absorptiometry, was e3.1.
Computed tomography of the neck showed three enlarged
parathyroid glands (Fig. 2). Fig. 3 represents a 2-hour
delayed 99mTc-sestamibi scintigraphy (MIBI scan) showing
an increased uptake in the right inferior parathyroid gland.
During the neck exploration, four enlarged, soft, oval, and
yellowish parathyroid glands were observed (right superior:
1.8  1.5 cm2; right inferior: 1  1 cm2; left superior:
1  0.7 cm2; left inferior: 2.5  1.8 cm2). Frozen biopsy
performed intraoperatively on the left superior parathyroid
revealed parathyroid hyperplasia. Left superior parathyroid
gland was preserved partially, while other lesions were
removed completely.
Histological findings revealed a parathyroid carcinoma
on a 1.7  1.5  1.0 cm3 mass of the right superior para-
thyroid gland; its capsular penetration was present and
vascular or perineural invasion was absent. Its surgical
resection margin was clear. Histological evaluationfrom kidney transplantation to subtotal parathyroidectomy.
Ca Z ionized calcium; iPTH Z intact parathyroid hormone;
Figure 2 Enlarged parathyroid glands in computed tomography. (A) Right superior parathyroid (arrow); (B) left superior para-
thyroid (arrow); (C) right superior parathyroid (arrow) and left inferior parathyroid (arrowhead); and (D) left inferior parathyroid
(white arrow) and right inferior parathyroid (dotted arrow). Right inferior parathyroid was mistakenly identified as a lymph node on
initial computed tomography. Intraoperative findings confirmed it to be a right inferior parathyroid.
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thyroid hyperplasia (Fig. 4).
During follow-up, the patient did not have any serious
postoperative complications. Postoperative blood testsFigure 3 MIBI scintigraphy. (A) MIBI uptake in both thyroid areas
inferior parathyroid 2 hours after MIBI injection. Uptake lesion wa
thyroid. MIBI Z 99mTc-sestamibi.performedaday after theoperation showeddecreased levels
of serumCaand iPTH,whichwere 8.5mg/dL and 43.6 pg/mL,
respectively. However, a slightly increased value was noted
for iPTH level on the follow-up after 3 months of the20 minutes after MIBI injection and (B) MIBI uptake in the right
s identified intraoperatively as a migrated right superior para-
Figure 4 (A) Microscopic finding shows infiltrative parathyroid carcinoma with growth into adjacent fatty tissue (H&E stain,
12.5). (B) Another microscopic finding displays confluent solid nodules penetrating into fibrofatty tissue adjacent to parathyroid
carcinoma (H&E stain, 40). (C) Diffuse parathyroid hyperplasia (H&E stain, 40). (D) Parathyroid hyperplasia with sheets of chief
cells and scattered fat cells (H&E stain, 100). H&E Z hematoxylin and eosin.
258 B.S. Kim et al.operation. No evidence of local recurrence or distant
metastasis was noted on the positron emission tomogra-
phyecomputed tomography scan, and neck ultrasonography
was performed 6 months after the operation. One year
postoperatively, his iPTH level continued to decrease to
114.1 pg/mL, andCaandALP levelswerewithin normal range
(9.6 mg/dL and 322 IU/L, respectively). In addition, the T-
score of L4 spine improved markedly (from 3.1 to 1.2).3. Discussion
Tertiary hyperparathyroidism is defined as persistent para-
thyroid hyperfunction developing from the secondary hyper-
plasia that occurs after restoration of renal function.2
Parathyroid pathology in patients with tertiary hyperpara-
thyroidismmostly revealsmarkedhyperplasia.3 Thepatient in
our study underwent subtotal parathyroidectomy for uncon-
trolled hyperparathyroidism after kidney transplantation.
Subsequent histological findings confirmed one of four para-
thyroid lesions to be an unexpected parathyroid carcinoma
and the others as diffuseparathyroid hyperplasia.On thebasis
of the histological confirmation of a parathyroid carcinomaand the finding of high iPTH level, we diagnosed this case as
parathyroid carcinoma in tertiary hyperparathyroidism.
Considering that the operation was performed only 4
months after the kidney transplantation, it is unclear when
the parathyroid carcinoma developed. Some reports have
suggested that chronic renal failure is associated with the
development of parathyroid carcinoma.4,5 Therefore, para-
thyroid carcinoma may develop during secondary hyper-
parathyroidism. Some studies showed that the incidence of
endocrinologic cancer was increased more after kidney
transplantation than prior to the transplantation.6,7 A study
reported that cumulative incidence of nonskin malignancy
after kidney transplantation was 1.2% at Month 3.7 Immu-
nosuppressive agents such as azathioprine and calcineurin
inhibitors are most linked with post-transplant malig-
nancies.8 However, there was no report on the occurrence of
parathyroid carcinoma. Further studies are necessary to
clarify the underlying mechanism for the development of
parathyroid carcinoma.
Some studies have suggested that significantly high level
of serum Ca is a positive predictive factor for parathyroid
carcinoma in patients with primary hyperparathyroid-
ism.1,9,10 However, it should be noted that the Ca level is
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with end-stage renal disease, as the kidney does not
respond to parathyroid hormone in such patients. Although
parathyroid carcinoma and hyperplasia can be expected to
increase serum Ca level significantly once renal function
recovers in response to high iPTH, only a slight increase in
its level was observed in our case. Therefore, Ca level do
not seem to be useful indicator of parathyroid carcinoma in
secondary or tertiary hyperparathyroidism.
MIBI scanning is a useful modality for localization of
abnormal parathyroid lesions in hyperparathyroidism.11
However, the role of a MIBI scan in diagnosing parathyroid
carcinoma in secondary or tertiary hyperparathyroidism is,
as yet, not clear.12 The MIBI scan can be used as an indicator
of proliferative parathyroid gland activity.13 Parathyroid
carcinoma can be assumed to have higher proliferative ac-
tivity than parathyroid hyperplasia. Therefore, when a
lesion of parathyroid carcinoma coexists with other lesions
of parathyroid hyperplasia, an increased uptake in the MIBI
scan is suggestive of parathyroid carcinoma.
In our case, a 2-hour delayed MIBI scan showed an
increased uptake in the right inferior gland. However,
parathyroid carcinoma was later found in the right superior
parathyroid gland. This discordance can be due to the fact
that the superior parathyroids, when tumorous, maymigrate
posteriorly and inferiorly, and often appear as higher uptake
in the inferior location on MIBI scan.14 In fact, we identified
migrated right superior parathyroid tumors in posterior and
inferior positions, intraoperatively. Single-photon emission
computed tomography MIBI scan is helpful in differentiating
between superior and inferior parathyroid lesions.15,16
Postoperative laboratory findings for iPTH level were
dynamic: it decreased to 43.6 pg/mL on postoperative Day
1, increased to 288.3 pg/mL 3 months following the oper-
ation, and then decreased again to 114 pg/mL. Such find-
ings may be explained by the recurrence of tumor.
However, its possibility was considered minimal, because
iPTH level decreased without any treatment and imaging
studies were inconsistent. We assumed that the remaining
hyperplastic parathyroid tissues were impaired transiently
in the immediate postoperative period and regained their
function afterward. Some studies showed that 24e35% pa-
tients with parathyroid adenoma had increased levels of
iPTH 8 weeks after parathyroidectomy,17,18 which implied
diminished Ca absorption and increased bone turnover with
cortical bone remineralization.18 Therefore, in our case, an
increased iPTH level after parathyroidectomy may be
attributed to bone remineralization.References
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